Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RVL Pharmaceuticals, Inc.

Home Clinical Trial Sponsors and OrganizationsRVL Pharmaceuticals, Inc.

RVL Pharmaceuticals, Inc.

ACTIVE

400 Crossing Blvd, 新泽西州桑莫塞县, New Jersey, United Stateswww.rvlpharma.comPublic101–250 employeesEstablished: 2000-01-01

Part of Osmotica Pharmaceutical Corp.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

10

1 active

Approvals

2

Total approvals

Agencies

1

Regulatory bodies

Founded

2000

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

9

90.0%

Phase 1

1

10.0%

Trial Status Distribution

Completed

8

80.0%

Not yet recruiting

1

10.0%

Withdrawn

1

10.0%

Clinical Trials

Trials sponsored by this organization (10)

A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis

Not yet recruiting

Jan 2027442 participants

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

Jun 2018164 participants

Study of Safety of RVL-1201 in Treatment of Blepharoptosis

Jun 2018234 participants

A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS

Apr 2018323 participants

A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS

Jan 2018536 participants

To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS

Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis

May 2015140 participants

Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis

May 201346 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

2

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials10
Approvals2
News

Back to Organizations